Novo Nordisk is facing growing challenges in the obesity treatment market, with its stock down over 50% in the past year. The decline reflects rising competition, unmet expectations for new drugs, and regulatory uncertainty. U.S. based Eli Lilly has gained ground with its drug Zepbound, which shows greater average weight loss than Novo Nordisk’s Wegovy. While Novo Nordisk argues that comparisons are misleading due to dosage differences and...

TotalEnergies has announced a strategic partnership with the Tour de France, securing its position as the official energy sponsor for both the men’s and women’s races from 2026 through 2028. This move marks a significant step in the company’s broader effort to deepen its engagement with the French public and reinforce its visibility across the country. Beginning with the 113th edition of the Tour in 2026, TotalEnergies will...

Mars Incorporated’s proposed $36 billion acquisition of Kellanova, the parent company of Pringles and Kellogg’s cereals, is facing a formal investigation by the European Commission (EC)

American Express is set to launch a significant refresh of its U.S. Consumer and Business Platinum Cards later this year, marking the largest investment in the product’s history.

Dutch technology investor Prosus NV (XAMS-PRX) disclosed that its core headline earnings for the full year reached $7.4 billion, marking a 47% increase compared to the previous year and surpassing its financial goals, thanks to its growth in lifestyle e-commerce.